Pinpoint SurgeryHow about something on Stansberry’s latest – “Pinpoint Surgery” stock?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Charles, how ’bout a link to the tout. Does ARAY fit the bill?
Accuray Incorporated is a radiation oncology company. The Company develops, manufactures, sells and supports precise, innovative treatment solutions. The Company’s technologies are designed to deliver advanced radiation therapy, including radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy and adaptive radiation therapy tailored to the specific needs of each patient. The Company’s suite of products includes the CyberKnife Systems and the TomoTherapy Systems. The CyberKnife Systems are fully robotic stereotactic radiosurgery systems (SRS) and stereotactic body radiation therapy systems (SBRT), used to treat multiple types of cancer and tumors throughout the body. The TomoTherapy Systems are used to treat a wide range of cancers and tumors, and enable efficient daily imaging to ensure the accuracy of the patient position before each treatment delivery.
AND if there’s a robot involved here’s 10 for ya: THE WORLD’S TOP 10 MOST INNOVATIVE COMPANIES IN ROBOTICS… http://www.fastcompany.com/3026314/most-innovative-companies-2014/the-worlds-top-10-most-innovative-companies-in-robotic
Best2ALL!-Benjamin
Charles, perhaps NVDQ is the equity Stansberry is referring to:
http://novadaq.com/procedures/minimally-invasive-surgery/overview
Enjoy your your Memorial Day! Best-Ben
How about OTCPink penny stock: Elekta AB (EKTAF) being Mampilly at Stansberry’s ‘pinpoint surgery’ ‘guaranteed winner? EKTAF is heading up. It Closed $6.77 on 16 JUN 15. It is based in Sweden. Has 3696 employees. It has equipment in thousands of hospitals. It makes the ‘Gamma Knife’. At least I would watch for any announcements.
Company website: http://www.elekta.com/
The Lexsell Gamma Knife® PERFEXIONTM system, manufactured by Sweden-based Elekta
http://www.otcmarkets.com/stock/EKTAF/quote
https://www.google.com/search?q=EKTAF&ie=utf-8&oe=utf-8
http://www.morningstar.com/stocks/PINX/EKTAF/quote.html
The image from the teaser is right from this Accuray pamphlet poste b “Guest further down on June 19, 2015: http://www.accuray.com/sites/default/files/m-cln-023-1108_lsbrt-cs.pdf
Toyocoro: Good find. You are correct! At that ‘Accuray .pdf’ link you gave is the exact same ‘fading lung tumor’ ex-ray’s that Mampilly (Stansberry’s ‘pinpoint surgery’) shows in his ad attempting to get people to fork over thousands for his newsletter.
sogiam, it came to me as an email. Here’s a clip:
I’ve discovered a stock that could be biotech’s next blockbuster.
It reminds me of a small company I found back in 2000…
If you’d put $1,000 into that company (Intuitive Surgical) when I first recommended it on Wall Street, by now you’d have nearly $50,000… a 5,688% gain.
And that brings me to the situation we’re facing today…In short, the tiny company I’m now recommending has invented a device that’s revolutionizing cancer surgery on a scale I haven’t seen since 2000… and could very well be the greatest medical breakthrough in years. Personally – I haven’t been this excited about biotech since I quadrupled my money on genetic testing back in 2014.
Gary, a bit vague wouldn’t you say? Maybe to avoid the mighty, mighty Think-o-later 🙂
Best-Ben
I pulled ARAY 10 Q just for grins. It has some warts that might need precision surgery (grin) before it’s a buy. More later if I find something of interest. Maybe they’ll augment the tease.
how about NVDQ
Gary, have you ever thought about becoming an Irregular? I’d sure be nice to have another set of eyeballs on the fundamentals and the camaraderie is second to none. Best-Ben
Actually, I have considered it. Thanks for the encouragement! I hang out a lot at Value Forum.
Cheers,
Gary
What’s the name of the company?
ARAY
ARAY is at $5.90 or so, after a fall from $10/share about 6 months ago. The 5-year track is down from about $20/share. Analysts opinions (9) are “very Bearish”. Something is going on, as about 50% of stock is held by major institutions and major funds. Anyone know what?
which free eletter did this come from? has yet to hit my in box
Here’s more from the pitch:
“In short, pinpoint surgery works with a device that targets diseased tissue anywhere in the body… including the brain… head and neck… kidney… lung… pancreas… prostate… and spine — with pinpoint accuracy…
…from OUTSIDE the human body…
…and REMOVES it in a way you’ve probably never imagined possible. It’s something out of a science fiction movie…
And right now — the stock I’m recommending is the ONLY company on the market with FDA approval for the approach it follows…
But after waiting 5 years, I’ve determined that right now is the perfect time to make a “pro” speculation…
That’s because the company just signed a contract with one of the biggest hospital alliances in America, which provides healthcare solutions to nearly 60% of U.S. hospitals. This level of exposure could soon mean major changes to the standard of care for every man, woman and child in the U.S.”
I vote cyberknife.
http://www.cyberknife.com/cyberknife-overview/what-cyberknife.aspx?langtype=1033
Yup. It’s Accuray.
I think it is Novadaq. It is mention in the presentation of Standsberry’s pinpoint surgery that the stock they are talking about is selling for around $10. Accuray is at $6 and Novadaq is at $10. Novadaq was just approved by the FDA as was mentioned in Standsberry. It sounds like Novadaq is more what the investment is talking about.
Well, I thought when I was researching it was ARAY as well, however, the stock price did not match up. I did notice in viewing the NVDQ website they use the terminolgy PINPOINT often which ties into the tease terminology? I can’t find anything though about NVDQ signing with one of the biggest hosipal alliances whereas ARAY shows a couple large signings recently?
To al
l checked Yhaoo in finance and up comes the company profile for nvdq- a small company from Ontario Canada. It’s near $10 range, read the summary below –it even mentions “PINPOINT” FOR SURGERY.
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products and therapeutic devices for use by surgeons in the operating room and other clinical settings in the United States and internationally. The companys proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. It offers SPY Elite imaging system for use in coronary artery bypass graft surgery, cardiovascular surgery, plastic surgery, reconstructive surgery, microsurgery, organ transplant, and gastrointestinal surgery. The companys PINPOINT endoscopic fluorescence imaging system is used for traditional endoscope and to obtain fluorescence images on demand or in a simultaneous imaging mode during minimally invasive surgery; and LUNA imaging system enables physicians treating chronic wounds to distinguish perfused and non-perfused tissue during the treatment of diabetic foot ulcers, pressure sores, and other serious chronic non-healing wounds. It also provides DermACELL tissue products for use in breast reconstruction surgeries, as well as in the treatment of diabetic foot ulcers and chronic non-healing wounds. In addition, the company offers Firefly imaging systems for use in robotic surgery; SPY analysis toolkit, a post-processing software that allows physicians to enhance and apply objective analysis tools to SPY Elite and LUNA images; and CO2 heart laser system for transmyocardial revascularization. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.
Seems to be NOVADAQ. Signed agreement w/ Intuitive surgical in 2011(?) and others later, as well. Checked out https://clinicaltrials.gov/ct2/results?term=novadaq&Search=Search
Determines tissue viability via perfusion of ICG to assist in determining patient recovery times. CMS approved payment as an outpatient medical procedure. Don’t see much excitement as a 5,000% monster stock, but probably a double if bought by Intuitive surgical or similar.
Judy, you ought to be an Irregular, too. You’ll find the $49 well-spent.
I don’t think it is NVDQ. this company only assists with surgery. The topic in Stansberry discusses the surgical process. a big difference
Novadaq appears to be a type systems that allows you see or find the affected area…like and exray… where Accuray is a treatment for cancer…I would go with this. Can anyone find out if the just signed big contracts with major hospitals????
so is it ARAY or NVDQ? Is ARAY a worthwhile investment?
Both are held in high numbers by the money makers but I can’t pinpoint it.
I’ve been in NVDQ, but sold out a month or so ago. It may be a CAR-T play as it is pinpoint and outside the body. Dr. Eifrig has touted this before. Alternately, Accurexa is a Ab nano particle that under magnetic induction kills the CA and sounds like SF, but not the right price range.
So we have two candidates for the tease and no agreement yet on which or what company is being teased
“Uncle Albert/Admiral Halsey” By Paul McCartney
https://www.youtube.com/watch?v=XsWufNDJl4M It fit’s ARAY website: http://www.accuray.com/ pretty well with no further information. Best-Ben
I agree with sogiam’s assessment above. The email from Stansberry says the price is under $10 which ARAY is and NVDQ is not. Also, NVDQ offer imaging solutions, with “pinpoint” imaging accuracy. But these are for use in traditional surgery, not something new and alternative.
The only thing is he says it isn’t a traditional play. So does he mean options or something totally different.
You’re talking $6, $10 stock… Stansberry guy obviously composed his presentation over a period of time. Mid April, ARAY was a $10 stock before it got hit by bad earnings.
Gosh!!! Youre paying $2500 to get info about a stock that was $10 and is now $6….bargain!!!!
I believe ARAY it appears to be more of a treatment for cancer as mentioned in the tease and NVDQ appears to be more of a tool or device like an ex-ray that would help you see the affected area better. The also mention just signing with a big hospital anyone got any info this this????
Travis, Could you provide further insight into the company touted by Paul Mampilly?
BIOZF, Biotie- I know Alan is gonna throw tomatoes at me 😉 https://globenewswire.com/news-release/2015/05/25/738679/0/en/Biotie-announces-agreement-with-FDA-on-a-Special-Protocol-Assessment-for-tozadenant-Phase-3-study.html Best2ALL-Benjamin!
It is ARRY recently almost $10 just within the last two months.
ARAY not ARRY, sorry
Using our collective Think-O-Lator hats, I think we have come up with ARAY as the teased “pinpoint surgery” stock…thanking you all for your inputs and mystery-solving skills
I agree with giving a preference to ARAY. However, there’s a Swedish company named Elektra AB that produces a somewhat similar external treatment system called GammaKnife utilizing nuclear radiation, and is regulated by the NRC. There are two U.S. symbols EKTAY and EKTAF, both priced slightly over $7.
I found that Cooper University has a new treatment center around 3 miles from my home in Moorestown, NJ that features both kinds of external radiation treatment. Here’s a link:
http://www.cooperhealth.org/treatments/radiosurgery
Any more comments? We would particularly welcome one from you, Travis, if you happen to read this.
I could not find any indication that ARAY received the big contract mentioned in the tease. Does anyone have any information on this issue as to ARAY or Elektra or anyone else?
It is ARAY and has been confirmed.
Chuck, if you go to the ARAY website under press releases I found several key strategic alliances but the most recent is with Premeir with over 3,000 hospitals and an additional 100,000 contacts. I also checked other reference such as the Stanford Study and others and find references to these as well so I am pretty sure the company is ARAY at this point. The analysis for this has recently joined Stansbury newletter but prior to that I believe he was with Agora Publishing?
Thanks. It sounds like you have found what I was looking for. I was drawn to ARAY years ago and followed it now and then. It has always suffered from less than stellar management. They still can’t seem to make a profit. Maybe this contract will pay off and give it the lift-off it needs. Today it dropped below $6 a share, so the price is getting more interesting. Of course the drop from near $10 was due to “earnings” (really a bigger loss than anticipated) disappointment.
I agree ARAY is the logical choice, and with this information about the hospital contracts, it makes selecting ARAY more solid….. so what else are we waiting for????
Accuray Inc (ARAY) signed 3-year contracts with Amerinet and Novation in May of 2014.
http://www.itnonline.com/article/accuray…solutions-contract-premier-inc
September 9, 2014 — Accuray Inc. announced it has been awarded a new exclusive three-year group purchasing agreement with Premier Inc., covering the CyberKnife …
Could this be the agreement?
It’s interesting that Cyberknife got an FDA approval in 2001 and Accuray’s business hasn’t been succeded for 14 years. Agreement with Premier sounds good, but I am a bit sceptic.
What’s your opinion about it?
I was in ARAY years ago, probably from a teaser ad. It was at the time that they were just turning profitable I researched and decided that they were going to announce earnings and go from losing $.07/shr to making $.07/shr. I bought shares and calls and they did make $.07 at the next earnings but when they announced earnings management had awarded $.06/shr. to themselves as bonuses and only$.01/shr. was left for shareholders who then proceeded to sell the stock down to approximately 50% of the pre-earnings value. I have not owned ARAY since.
http://www.tucc.com/SBRT-Cyberknife-for-prostate-cancer-may-result-in-more-complications.29.564.html
It is definitely ARAY.
In this trial 55 patients with medically inoperable peripheral tumors (non-small cell lung cancer stages 1A and 1B) were given three treatments of SBRT. They had tumor control in 98% of the patients, 72% survival at two years and a median overall survival of 48 months.
How disappointing. At the present time, the tease falls flat on its face.
The hospitals around Newport Beach, CA have had all of ARAYs products and been a showplace for them for years. It is a very impressive bunch of VERY expensive machines that do things that were unimaginable 15 years ago. There is very little collateral damage to surrounding tissues from SBRT. They have some problems, though.:
1) There is no way to tell if the tumor margins are clear. The tumors treated by SBRT can recur both locally and distantly.
2) It is radiation. It is taken up by the surrounding cells and once it reaches a sufficient cumulative dose, the cells surrounding the treatment zone mutate and the blood vessels that supply the tissue close off.
To make the treatment truly astounding, you need to be able to repeat it without causing damage. Hi intensity focused ultrasound (HIFU) seems to meet this criteria. No, it doesn’t tell you if your margins are clear. You might need to examine the peripheral blood for exosomes or circulating cancer cells to look for that. HIFU is in use around the world. A private company, InSightec http://www.insightec.com/MRgFUS-Technology.html has been at the center of this technology for a long time. It is a truly disruptive technology.
There are a few TED talks on it. Here is one that I think illustrates the principles well:
https://www.youtube.com/watch?v=x4lA-M3zbdU
Unless ARAY wants to incorporate HIFU, I don’t think it has too much room to grow from here.
Cheers.
Thanks, eyedoc. I agree with you. Maybe InSightec will be spun off as a separate entity some day. That might be worth considering. ARAY is not that attractive to me (and the price is still dropping today, on an up day, after all the Stansberry touting).
That TED talk was wonderful. This concept gives options that didn’t exist before.
Ok, now weve cracked that one, try this. Its a loooong video, so run it, immediately exit it and when you get the message, hit stay on page for the text which you can skim. http://pro.oxfordclub.com/CDC499ORERIBRKJV/EIUPR545/?email=runningrep%40btinternet.com&a=9&o=2650&s=3408&u=2262195&l=174401&r=MC2&g=0&h=true
Best pick Paul has given in the past was AVEO ! Supposedly a stock that he said would jump 600% when it was $1.75 Back in June 2014.
Check it out ……I am making money with AVEO!
I 3Xed AVEO this morning, 5 minutes before the bump… I follow robotics, but the AAPL suppliers (especially AVEO & QROV) are better plays… MZOR is interesting…
http://globalbiodefense.com/2014/07/22/cdc-award-genome-sequencing-meningococcus/
Pacific BioSciences PACB
Would appreciate any advise how to play this one if anyone would like to offer advise.
Damn we’re getting good at this….perhaps Travis should throw out the tease to us guys (refines our sleuthing) before unleashing the mighty mighty thinkolator.
This must be a Proton beam radiation equipment co. of small accelerators. Don’t know the name of the co. , but new Proton beam radiation centers are build all over the country & the world. It is the most accurate radiation with min. side effects.
Hope this might help.
Kaz
You might want to read Wikipedia to learn about Proton Beam Radiation vs SBRT and HIFU. This is a complex area. Making blanket statements about Proton Beam radiation only helps facilities spread false information and contributes to patients making the wrong treatment decisions. Each mode of therapy has its place. The costs for each is quite different.
http://en.m.wikipedia.org/wiki/Proton_therapy
Tumors recur. Only HIFU is truly repeatable in every situation it is used. There is no collateral, cumulative tissue poisoning as in radiation applications. The accuracy has to be seen to be believed. Unfortunately, it is only available for prostate, fibroid/GYN and neurosurgical applications and only at specific locations.
BTW after 10 seconds, KSS thought $PACB too.